Pasithea Therapeutics Warrants
KTTAW
6 hedge funds and large institutions have $9.59K invested in Pasithea Therapeutics Warrants in 2025 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
20% more funds holding
Funds holding: 5 → 6 (+1)
13.73% less ownership
Funds ownership: 63.27% → 49.55% (-14%)
59% less capital invested
Capital invested by funds: $23.5K → $9.59K (-$13.9K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$273 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$3.99K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
KC
1
Kepos Capital
New York
| $6K | – | – | – |
|
|
WAM
2
Warberg Asset Management
Winnetka,
Illinois
| $2.03K | -$3.99K | -154,701 | -61% |
|
|
AC
3
Armistice Capital
New York
| $910 | – | – | – |
|
|
MG
4
Marex Group
London,
| $460 | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $193 | +$273 | +10,579 | New |
|
|
CS
6
Clear Street
New York
| $1 | – | – | – |
|
KTTAW Hedge Fund Activity: Q1 2025 in Review
6 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Pasithea Therapeutics Warrants (KTTAW) for Q1 2025, worth a combined $9.59K — down 59% from $23.5K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new KTTAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $273. The largest seller was Warberg Asset Management, cutting an estimated $3.99K.
- 6 institutional investors held Pasithea Therapeutics Warrants (KTTAW) as of Q1 2025, up from 5 in Q4 2024.
- Funds reported $9.59K of Pasithea Therapeutics Warrants stock for Q1 2025, down 59% quarter-over-quarter.
- 1 fund opened new Pasithea Therapeutics Warrants positions in Q1 2025 and 0 closed out, a net change of +1 holder.
- The largest Pasithea Therapeutics Warrants buyer in Q1 2025 was Susquehanna International Group, an estimated $273 added.
- The largest Pasithea Therapeutics Warrants seller in Q1 2025 was Warberg Asset Management, an estimated $3.99K sold.
Based on aggregated 13F filings for Q1 2025.